Phase II study of moplace chemotherapy f
β
Schulman, Philip ;McCarroll, Kathleen ;Robert Cooper, M. ;Norton, Larry ;Barcos,
π
Article
π
1990
π
John Wiley and Sons
π
English
β 452 KB
## Abstract To further evaluate possible nonβcrossβresistant regimens in Hodgkin's disease, a phase II trial utilizing antimetabolites and etoposide was initiated by the Cancer and Leukemia Group B (CALGB). Etoposide was included because of its known efficacy in relapsed Hodgkin's disease and to ev